Australia · Delayed Price · Currency is AUD Nova Eye Medical Statistics
Total Valuation
ASX:EYE has a market cap or net worth of AUD 38.46 million. The enterprise value is 39.89 million.
| Market Cap | 38.46M |
| Enterprise Value | 39.89M |
Important Dates
The next estimated earnings date is Tuesday, November 24, 2026.
| Earnings Date | Nov 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:EYE has 284.88 million shares outstanding. The number of shares has increased by 15.03% in one year.
| Current Share Class | 284.88M |
| Shares Outstanding | 284.88M |
| Shares Change (YoY) | +15.03% |
| Shares Change (QoQ) | -0.47% |
| Owned by Insiders (%) | 6.81% |
| Owned by Institutions (%) | 17.46% |
| Float | 233.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.10 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 4.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.74 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.71 |
| Interest Coverage | -28.41 |
Financial Efficiency
Return on equity (ROE) is -26.07% and return on invested capital (ROIC) is -27.86%.
| Return on Equity (ROE) | -26.07% |
| Return on Assets (ROA) | -11.37% |
| Return on Invested Capital (ROIC) | -27.86% |
| Return on Capital Employed (ROCE) | -27.24% |
| Weighted Average Cost of Capital (WACC) | 9.15% |
| Revenue Per Employee | 115,831 |
| Profits Per Employee | -14,395 |
| Employee Count | 301 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 3.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.47% in the last 52 weeks. The beta is 0.94, so ASX:EYE's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -8.47% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 48.52 |
| Average Volume (20 Days) | 202,279 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:EYE had revenue of AUD 34.87 million and -4.33 million in losses. Loss per share was -0.02.
| Revenue | 34.87M |
| Gross Profit | 25.01M |
| Operating Income | -4.38M |
| Pretax Income | -4.33M |
| Net Income | -4.33M |
| EBITDA | -3.41M |
| EBIT | -4.38M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 964,000 in cash and 2.39 million in debt, with a net cash position of -1.43 million or -0.01 per share.
| Cash & Cash Equivalents | 964,000 |
| Total Debt | 2.39M |
| Net Cash | -1.43M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 14.28M |
| Book Value Per Share | 0.05 |
| Working Capital | 4.09M |
Cash Flow
In the last 12 months, operating cash flow was -3.15 million and capital expenditures -235,000, giving a free cash flow of -3.38 million.
| Operating Cash Flow | -3.15M |
| Capital Expenditures | -235,000 |
| Depreciation & Amortization | 962,000 |
| Net Borrowing | -657,000 |
| Free Cash Flow | -3.38M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 71.74%, with operating and profit margins of -12.55% and -12.43%.
| Gross Margin | 71.74% |
| Operating Margin | -12.55% |
| Pretax Margin | -12.43% |
| Profit Margin | -12.43% |
| EBITDA Margin | -9.79% |
| EBIT Margin | -12.55% |
| FCF Margin | n/a |
Dividends & Yields
ASX:EYE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.03% |
| Shareholder Yield | -15.03% |
| Earnings Yield | -11.27% |
| FCF Yield | -8.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for ASX:EYE is 0.43, which is 207.14% higher than the current price. The consensus rating is "Buy".
| Price Target | 0.43 |
| Price Target Difference | 207.14% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 21.22% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 10, 2001. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jul 10, 2001 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
ASX:EYE has an Altman Z-Score of 1.6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.6 |
| Piotroski F-Score | 3 |